Evaluating the efficacy of a priming dose of cyclophosphamide prior to pembrolizumab to treat metastatic triple negative breast cancer

Carey K. Anders, Jonathan S. Serody, Amanda E.D. Van Swearingen et al.|Journal for ImmunoTherapy of Cancer|2022

Cited by 28